Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CRM | Common Stock | Options Exercise | $1.47M | +12.5K | +29.42% | $118.04 | 54.8K | Mar 7, 2022 | Direct | F1 |
transaction | CRM | Common Stock | Options Exercise | $570K | +7.54K | +13.75% | $75.57 | 62.4K | Mar 7, 2022 | Direct | F1 |
transaction | CRM | Common Stock | Sale | -$3.62M | -17.8K | -28.54% | $203.50 | 44.6K | Mar 7, 2022 | Direct | F1, F2 |
transaction | CRM | Common Stock | Sale | -$449K | -2.2K | -4.94% | $204.14 | 42.4K | Mar 7, 2022 | Direct | F1, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CRM | Non-qualified Stock Option (Right to Buy) | Options Exercise | $0 | -12.5K | -13.27% | $0.00 | 81.5K | Mar 7, 2022 | Common Stock | 12.5K | $118.04 | Direct | F1, F4 |
transaction | CRM | Non-qualified Stock Option (Right to Buy) | Options Exercise | $0 | -7.54K | -100% | $0.00* | 0 | Mar 7, 2022 | Common Stock | 7.54K | $75.57 | Direct | F1, F5 |
Id | Content |
---|---|
F1 | The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. |
F2 | Weighted average price. These shares were sold in multiple transactions at prices ranging from $202.9500 to $203.9100 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
F3 | Weighted average price. These shares were sold in multiple transactions at prices ranging from $203.9500 to $204.4900 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
F4 | Option is exercisable and vests over four years at the rate of 25% on March 22, 2019, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |
F5 | Option is exercisable and vests over four years at the rate of 25% on November 22, 2017, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |